A new study from researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) has uncovered a way the body controls a group of specialised immune cells called unconventional T cells, which are known for their rapid response to disease.

The study, ‘Selective regulation of IFN-γ and IL-4 co-producing unconventional T cells by purinergic signaling’, is published in Journal of Experimental Medicine.

This article was adapted from an original article by the Peter Doherty Institute for Infection and Immunity.